نتائج البحث - "Lea C, Berkhout"

1

دورية أكاديمية

Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors

المصدر: Clinical & Translational Immunology, Vol 10, Iss 5, Pp n/a-n/a (2021)

مصطلحات موضوعية: ACE2‐competitive ELISA, antibodies, COVID‐19, longitudinal, neutralisation, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2050-0068

URL الوصول: https://doaj.org/article/90bc47650aa74ada89a585d8baee315c

View record at Wiley

Find this article in full text from ProQuest

Full Text Finder

2

The effect of methotrexate on tumour necrosis factor concentrations in etanercept-treated rheumatoid arthritis patients

المؤلفون: Charlotte L M Krieckaert, Lea C. Berkhout, Michael T. Nurmohamed, Gerrit Jan Wolbink, Theo Rispens, Dorien Kos, Erik H Vogelzang, Merel J l'Ami

المساهمون: AII - Inflammatory diseases, Graduate School, Landsteiner Laboratory, ACS - Atherosclerosis & ischemic syndromes, Rheumatology

المصدر: Rheumatology (Oxford, England), 59(7), 1703-1708. Oxford University Press
Rheumatology (United Kingdom), 59(7), 1703-1708. Oxford University Press
Berkhout, L C, L'Ami, M J, Krieckaert, C L M, Vogelzang, E H, Kos, D, Nurmohamed, M T, Wolbink, G J & Rispens, T 2020, ' The effect of methotrexate on tumour necrosis factor concentrations in etanercept-treated rheumatoid arthritis patients ', Rheumatology (United Kingdom), vol. 59, no. 7, pp. 1703-1708 . https://doi.org/10.1093/rheumatology/kez513

مصطلحات موضوعية: 0301 basic medicine, musculoskeletal diseases, Adult, medicine.medical_specialty, Necrosis, medicine.medical_treatment, TNF, immunogenicity, MTX, Gastroenterology, Etanercept, Arthritis, Rheumatoid, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Interquartile range, Internal medicine, medicine, Adalimumab, Humans, Pharmacology (medical), skin and connective tissue diseases, 030203 arthritis & rheumatology, business.industry, Tumor Necrosis Factor-alpha, medicine.disease, 030104 developmental biology, Cytokine, Methotrexate, Treatment Outcome, Rheumatoid arthritis, Antirheumatic Agents, Tumor necrosis factor alpha, Drug Therapy, Combination, medicine.symptom, business, RA, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043af7d6f3a7e658f88e864aa6c630e2
https://pubmed.ncbi.nlm.nih.gov/31691828

3

FRI0096 TNF CONCENTRATIONS DURING TREATMENT OF INFLAMMATORY DISEASES WITH GOLIMUMAB

المؤلفون: Annick de Vries, Lea C. Berkhout, Michael T. Nurmohamed, Merel J l'Ami, Femke Hooijberg, Sadaf Atiqi, Theo Rispens, Gertjan Wolbink, C. Krieckaert

المصدر: Poster Presentations.

مصطلحات موضوعية: medicine.medical_specialty, Ankylosing spondylitis, business.industry, Radioimmunoassay, medicine.disease, Gastroenterology, Rheumatology, Golimumab, Psoriatic arthritis, Interquartile range, Rheumatoid arthritis, Internal medicine, medicine, Adalimumab, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::33fc4a926387397620f0c9a9924b8a4c
https://doi.org/10.1136/annrheumdis-2019-eular.1908

4

AB0382 TROUGH VERSUS NON-TROUGH ADALIMUMAB DRUG LEVEL MEASUREMENTS

المؤلفون: C. Krieckaert, Sadaf Atiqi, Gertjan Wolbink, Merel J l'Ami, Lea C. Berkhout, Michael T. Nurmohamed, Femke Hooijberg, Annick de Vries, Theo Rispens

المصدر: Abstracts Accepted for Publication.

مصطلحات موضوعية: medicine.medical_specialty, medicine.diagnostic_test, business.industry, medicine.disease, Rheumatology, Etanercept, Quartile, Interquartile range, Therapeutic drug monitoring, Rheumatoid arthritis, Internal medicine, medicine, Adalimumab, Trough level, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::597b19bc2ec8230a070ec99e11c34aa8
https://doi.org/10.1136/annrheumdis-2019-eular.4098

5

The effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisation

المؤلفون: Lea C, Berkhout, Erik H, Vogelzang, Margreet M, Hart, Floris C, Loeff, Lisanne, Dijk, Ninotska I L, Derksen, Roeland, Wieringa, W Astrid, van Leeuwen, Charlotte L M, Krieckaert, Annick, de Vries, Michael T, Nurmohamed, Gerrit J, Wolbink, Theo, Rispens

المصدر: Clinical and experimental rheumatology. 38(2)

مصطلحات موضوعية: Arthritis, Rheumatoid, Immunoglobulin Fab Fragments, Tumor Necrosis Factor-alpha, Antirheumatic Agents, Adalimumab, Certolizumab Pegol, Humans, Antibodies, Monoclonal, Humanized, Antibodies, Neutralizing, Antibodies, Infliximab

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::266561cf597d9f5586a130c9fe2f9f1d
https://pubmed.ncbi.nlm.nih.gov/31498069

6

Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay

المؤلفون: Merel J l'Ami, Gerrit Jan Wolbink, Pleuni Ooijevaar-de Heer, Catherine H. Smith, Daniel F. Alvarez, M. Hart, M. T. Nurmohamed, Ronald F van Vollenhoven, Theo Rispens, Maarten Boers, Karien Bloem, Lea C. Berkhout, J. Ruwaard

المساهمون: Rheumatology, ACS - Atherosclerosis & ischemic syndromes, AII - Inflammatory diseases, Epidemiology and Data Science, APH - Methodology, Graduate School, Clinical Immunology and Rheumatology, AMS - Ageing & Morbidty, Landsteiner Laboratory

المصدر: Berkhout, L C, L'Ami, M J, Ruwaard, J, Hart, M H, Ooijevaar-De Heer, P, Bloem, K, Nurmohamed, M T, Van Vollenhoven, R F, Boers, M, Alvarez, D F, Smith, C H, Wolbink, G J & Rispens, T 2019, ' Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay ', Science Translational Medicine, vol. 11, no. 477, aat3356 . https://doi.org/10.1126/scitranslmed.aat3356
Berkhout, L C, l'Ami, M J, Ruwaard, J, Hart, M H, Ooijevaar-de Heer, P, Bloem, K, Nurmohamed, M T, van Vollenhoven, R F, Boers, M, Alvarez, D F, Smith, C H, Wolbink, G J & Rispens, T 2019, ' Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay ', Science Translational Medicine, vol. 11, no. 477, aat3356 . https://doi.org/10.1126/scitranslmed.aat3356
Science Translational Medicine, 11(477):aat3356. American Association for the Advancement of Science
Science translational medicine, 11(477):aat3356. American Association for the Advancement of Science